ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Top 5 Ways To Leverage eLogs In Clinical Research

  Unearth how embracing these specific approaches ensures that technology becomes a true ally in enhancing precision, accessibility, and collaboration within the intricate realm of clinical research.

• Exploring Integrations In Decentralized Clinical Trials

  In this blog, see how each decentralized clinical trial is unique and has its own set of requirements. Based on your trial’s design, consider how to plan for necessary system interactions, leverage the data collected, and select the right partner.

• Taking eCOA Technology Deployment Off The Critical Path

  Consider this expedited review approach to facilitate the efficient evaluation of COAs and eCOAs, streamlining the pathway for successful trial execution.

• Evaluating Usability And Incorporating The Patient Experience In DECODE-Nocturnal Scratch

  The DECODE-Nocturnal Scratch group, launched in November 2023, aims to introduce a purpose-built digital measure of nocturnal scratching to enhance patient-focused drug development in dermatology and provide deeper clinical insights.

• On-Site ePRO In Action

  Bridge the gap between clinic and home with flexible data capture. Use any device to ensure consistent, real-time data entry and improve compliance throughout the study lifecycle.

• Keep Up With These 5 Patient Engagement And Recruitment Trends

  From decentralized trials to real world data, take a look at top trends, their impact on patient enrollment and more, as well as ways to stay ahead of the curve.

• Bridging The Knowledge Gap On Digital Clinical Measures: A Technology Partner's Perspective On The 'The Playbook'

  ActiGraph CEO, Jeremy Wyatt, shares his perspectives on The Playbook, the essential guide for remote patient monitoring in clinical research, clinical care and public health, compiled by the Digital Medicine Society (DiMe).

• Achieving Faster, Simpler Validation Through Crowdsource UAT

  An approach most often seen in the larger tech space, crowdsource UAT can offer several potential advantages for the clinical trial industry and eTMF validation.

• Embracing Accessibility: The Future Of Clinical Trials

  Explore the reasons why accessibility stands as a crucial pillar for the prosperity of biopharmaceutical and clinical research, having evolved into an all-encompassing industry imperative.

• The Strategic Case For RTSM in Phase 1 Trials

  Phase 1 trials demand precision and speed. RTSM delivers real-time control over enrollment, dosing, and supply, reducing risk and enabling adaptive strategies that keep timelines on track.